1. Introduction
===============

Hereditary deficiencies of early components of the classical pathway of the complement system are known to predispose to systematic lupus erythematosus (SLE). Among these, C1q deficiency exhibits the strongest association with prevalence greater than 90% suggesting that a physiological activity of the early part of the classical pathway normally protects against the development of SLE ([@bib37]). Mice with targeted deletion of the C1q gene (*C1qa*^−/−^) developed a spontaneous lupus-like disease characterised by the development of anti-nuclear autoimmunity and glomerulonephritis associated with the presence of multiple apoptotic bodies ([@bib3]). Introgression of C1q deficiency onto different genetic backgrounds revealed that in mice C1q operates as a disease modifier. C57BL/6.*C1qa*^−/−^ mice displayed no increase of IgG autoantibodies (autoAbs) or glomerulonephritis ([@bib32]), whilst C1q deficiency backcrossed onto the lupus-prone MRL/Mp background accelerated both the onset and the severity of the autoimmune disease ([@bib32]). Consistent with these observations, C1q reconstitution by bone marrow transplant attenuated the autoimmune disease present in MRL/Mp.*C1qa*^−/−^ mice ([@bib13]).

Currently, there are two main hypotheses to explain the role of complement in the development of SLE, neither of which is mutually exclusive. The first model, defined as the tolerance hypothesis, proposes a role for complement in determining the activation thresholds of lymphocytes, whereby complement enhances presentation of autoantigens to self-reactive immature B cells resulting in their elimination ([@bib39]). The second one, known as the 'waste disposal' hypothesis, suggests that in addition to its role in the clearance of immune complexes, complement is involved in the physiological disposal of apoptotic cells ([@bib3]), that have been shown to express lupus autoantigens on their surface ([@bib8]). C1q plays a significant role in the clearance pathway of cellular debris by binding directly or indirectly to apoptotic blebs where it activates complement and mediates phagocytosis by professional and non-professional phagocytes ([@bib23; @bib31; @bib34; @bib41; @bib47]). Therefore, improper removal of dying cells in the setting of C1q deficiency could result in the stimulation of autoreactive cells leading to autoimmunity.

Immunoglobulin Tg models have been instrumental in understanding B cell regulation revealing several key mechanisms, including receptor editing, deletion, anergy and ignorance. The hen egg lysozyme (HEL)--anti-HEL (Ig^HEL^) Tg model in particular has been widely used to demonstrate elimination of self-reactive clones by membrane-bound expressed antigen, anergy induction by soluble antigen (sHEL) or ignorance when the amount of antigen is so low that it does not reach the threshold to induce anergy. More recently, it has been shown that intracellular membrane-bound HEL failed to induce tolerance and was instead autoimmunogenic positively selecting Ig^HEL^ B1 cells and inducing large numbers of IgM autoantibody-secreting plasma cells (reviewed in [@bib18]). Taken together, these findings suggest that in this model the fate of self-reactive B cells is determined not only by the abundance, the avidity of the target self-antigen and the affinity of the B cell receptor but also by the location of the "auto"-antigen. The role of complement has been tested in the Ig^HEL^ Tg (MD4)--sHEL (ML5) model by crossing the double Tg mice with mice deficient in C1q, C4, C3 or CD21/CD35 ([@bib14; @bib39]). IgG anti-HEL Abs remained undetectable in all complement deficient mice, but C4 and CD21/CD35 deficient B cells displayed reduced surface IgM modulation, indicating a lower degree of anergy induction in these mice ([@bib39]). However, this was not observed in the C1q deficient mice ([@bib14]). This discrepancy could either indicate that C4 operates independently from C1q or reflect differences in the genetic background of the mice used ([@bib14]). Nevertheless sHEL is not the ideal model to study the maintenance of tolerance in SLE as it is neither a natural autoantigen, nor are soluble plasma proteins typically targeted by the SLE autoAbs.

More recently, a model targeting an SLE antigen, DNA, was generated by Weigert and co-workers ([@bib9]). In this model the rearranged variable heavy chain (V~H~) gene derived from a double stranded DNA-binding hybridoma developed in the autoimmune strain MRL/Mp.*lpr*/*lpr*, was inserted at the Igh locus and was referred to as V~H~3H9R. In contrast to conventional Tg mice, this knock-in model allows the Tg locus to undergo normal editing, isotype switching and somatic mutation. A variety of light chains can combine with the V~H~3H9 to yield anti-DNA Abs ([@bib42]) but only few light chains are able to "silence" V~H~3H9R so that it no longer binds to DNA. By virtue of this characteristic the mice expressing only the V~H~3H9 chain (V~H~3H9R mice) can generate anti-DNA specificities. However, when the V~H~3H9R mice were crossed with a Tg knock-in light chain V~L~κ8 ([@bib38]) to generate monospecific Tg mice (V~H~3H9R/V~L~κ8R mice) ([@bib10]), this combination of heavy and light chain V regions (V~H~3H9/V~L~Vκ8) bound only ssDNA and not dsDNA ([@bib38]). Previous studies with the V~H~3H9R mice have shown that the autoreactive Tg B cells accumulated in the splenic marginal zone and were regulated by anergy on non-autoimmune backgrounds such as BALB/c ([@bib9; @bib16]) and C57BL/6 ([@bib20; @bib45]). However, tolerance could be broken in this model if T cell help was provided in the form of a chronic graft versus host disease ([@bib45]). Consistent with these observations, the double V~H~3H9R/V~L~κ8R knock-in Tg B cells were regulated by anergy in non-lupus prone mice (BALB/c), whilst in autoimmune prone MRL/Mp.*lpr*/*lpr* animals Tg B cells escaped tolerance induction and underwent class-switching and affinity maturation ([@bib4]). These experiments suggested that the *lpr* mutation in the MRL background allowed the Tg autoreactive B cells to receive T cell help during a germinal center reaction.

To determine whether C1q is involved in selection of self-reactive B cells, we bred the C1q-deficient mice with the V~H~3H9R and the V~H~3H9R/V~L~κ8R mice and monitored the regulation and activation of anti-DNA Tg B cells over a period of 10 months. The mice in this study were on the autoimmune prone background MRL/Mp expressing the CD95 (*Fas*) gene. The analysis of these mice revealed that the lack of C1q can influence the levels of IgM and IgG~3~ Tg-derived antibodies only in the V~H~3H9R model.

2. Materials and methods {#sec1}
========================

2.1. Mice
---------

MRL/Mp mice were obtained from Harlan Olac, Bichester, UK. MRL/Mp.*C1qa*^−/−^ deficient mice were generated as previously described ([@bib32]). V~H~3H9R.MRL/Mp ([@bib9]), V~L~κ8R.MRL/Mp ([@bib38]) and V~H~3H9R/V~L~κ8R.MRL/Mp mice were kindly provided by Prof. M. Weigert (Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, IL). MRL/Mp.*C1qa*^−/−^ mice were crossed with the V~H~3H9R/Vκ8R.MRL/Mp mice and the resulting V~H~3H9R/V~L~κ8R.MRL/Mp.*C1qa*^+/−^ were then crossed either with MRL/Mp or MRL/Mp.*C1qa*^−/−^ in order to generate littermate animals. Mice were bled every 3 months starting from 2 months of age and at 10 months they were sacrificed. The mice were genotyped by PCR using specific primers. PCR primers were as follow: mC1qA/5′ (5′-GGGGCCTGTGATCCAGACAGG-3′), mC1qA/In2^−^ (5′-TAACCATTGCCTCCAGGATGG-3′) and neo (5′-GGGGATCGGCAATAAAAAGAC-3′) for the C1q genotyping; MW114 (5′-CTGTCAGGAACTGCAGGTAAGG-3′) and MW162 (5′-CATAACATAGGAATATTTACTCCTCGC-3′) for the V~H~3H9R genotyping ([@bib16]); MW133 (5′-GGTACCTGTGGGGACATTGTG-3′) and MW157 (5′-AGCACCGAACGTGAGAGG-3′) for the V~L~κ8R genotyping ([@bib7]). Animals were kept under specific pathogen-free conditions. All animal care and procedures were conducted according to institutional guidelines and approved by the local ethical committee.

2.2. Flow cytometry
-------------------

Flow cytometry was performed using a four-color staining of cells and analyzed with a FACSCalibur™ (Becton Dickinson, Mountain View, CA). The following Abs were used: anti-B220 (RA3-6B2), anti-CD5 (53-7.3), anti-CD11b (M1-70), anti-CD19 (1D3), anti-CD23 (B3B4), anti-CD21/CD35 (7G6), anti-CD90.2 (53-2.1), anti-CD138 (281-2), anti-IgM (II/41). All Abs were purchased from BD Biosciences Pharmingen (San Diego, CA) with the exception of the anti-V~H~3H9 idiotype (1.209), a kind gift from Prof. M. Weigert ([@bib21]). Biotinylated Abs were detected using an allophycocyanin-conjugated streptavidin Ab (BD Biosciences Pharmingen). Staining was performed in the presence of saturating concentration of 24G2 mAb (anti-FcRII/III). Data were analyzed using WinMDI software (Version 2.8; Scripps Institute).

2.3. Serological analyses
-------------------------

Serum levels of IgM and IgG were quantified by ELISA, as described previously ([@bib13]). Anti-ssDNA Abs, anti-chromatin Abs, anti-histone Abs and anti-dsDNA Abs were measured by ELISA as described previously ([@bib5; @bib15]). Microtiter plates were coated with ssDNA prepared from calf thymus DNA (Sigma), chromatin (Lorne Laboratories Ltd., Reading, UK) or histone (Calbiochem, Merck Biosciences, Darmstadt, Germany). For detecting anti-dsDNA Abs, plates were coated with streptavidin (Sigma). ΦX174 double-stranded plasmid DNA (Promega, Southampton, UK) was biotinylated with Photoprobe biotin (Vector Laboratories, Peterborough, UK) and added to the streptavidin. Serum samples were diluted appropriately in PBS 2%BSA, 0.05%Tween-20, 0.02% NaN~3~. Bound Abs were detected with alkaline phosphatase conjugated goat anti-mouse IgG (γ-chain specific) (Sigma--Aldrich, Dorset, UK) and anti-mouse IgM (Southern Biotechnology Associates, Inc., Birmingham, AL). All autoAb results are expressed in arbitrary ELISA units (AEU) in reference to a standard curve derived from serum pools containing high titers of autoAbs. The idiotype^+^ Abs were captured with the anti-V~H~3H9 idiotype (1.209) ([@bib21]) and detected with alkaline phosphatase conjugated goat anti-mouse IgM or IgG subclasses specific Abs (Southern Biotechnology Associates). The standard curve was derived from an IgM V~H~3H9R/Vκ8R mAb provided by Prof. Weigert or sera containing high IgG subclasses titers of the Tg.

2.4. Renal assessment
---------------------

Proteinuria was assessed using Haema-combistix (Bayer Diagnostics, Newbury, UK). Kidneys were fixed in Bouin\'s solution and paraffin embedded, and sections were stained with periodic acid--Schiff reagent. Glomerular histology was graded in a blind fashion scored on a scale of 0--4, as described before ([@bib6]).

2.5. Statistics
---------------

The data are presented as median, with range of values in brackets, unless otherwise stated. The non-parametric Mann--Whitney *U*-test was applied throughout with differences being considered significant for *p*-values \< 0.05. Statistics were calculated using GraphPad Prism Version 3.0 (GraphPad Software, San Diego, CA).

3. Results
==========

3.1. Expression of Tg autoantibodies
------------------------------------

C1q deficiency has been shown to accelerate the onset and progression of SLE in MRL/Mp mice ([@bib32]), but the mechanisms underlying these effects are still uncertain. The V~H~3H9R/V~L~κ8R Tg alleles were transferred onto C1q-deficient mice by crossing V~H~3H9R/V~L~κ8R.MRL/Mp with MRL/Mp.*C1qa*^−/−^ and experimental cohorts of littermate mice were generated. Whilst in previous studies the expression of the Tg alleles was monitored by measuring the Tg-specific immunoglobulin allotype ([@bib46]), this analysis could not be applied in these mice as the Tg alleles and the endogenous immunoglobulin allotype were indistinguishable. Nevertheless, we were able to detect the combination of the V~H~3H9 with the V~L~Vκ8 using an idiotype specific monoclonal Ab named 1.209 ([@bib21]). As the 1.209 mAb can also recognize the V~H~3H9 paired with other endogenous light chains such as V~L~κ4 ([@bib21]), this anti-idiotype Ab allowed us not only to assess the V~H~3H9R/V~L~κ8R Tg B cells but also some of the V~H~3H9R Tg B cells. C1q deficiency did not affect the proportion of peripheral blood B cells expressing the Tg in neither of the two models (V~H~3H9R/V~L~κ8R.MRL/Mp.*C1qa*^−/−^: 89.1 ± 1.1% versus V~H~3H9R/V~L~κ8R.MRL/Mp: 90.7 ± 1.5%, *p* = 0.4118; V~H~3H9R.MRL/Mp.*C1qa*^−/−^: 25.3 ± 1.6% versus V~H~3H9R.MRL/Mp: 22.3 ± 2.3% *p* = 0.1669). The low proportion of idiotype^+^ B cells in the V~H~3H9R.MRL/Mp mice indicated that most of the B cells in these mice had either paired the V~H~3H9R Tg allele with a light chain that was not recognised by the anti-idiotype Ab, or edited the V~H~3H9R allele, or used the endogenous immunoglobulin allele. In the V~H~3H9R/V~L~κ8R.MRL/Mp.*C1qa*^−/−^ mice the B cell receptor was down-modulated to the same extent as in the V~H~3H9R/V~L~κ8R.MRL/Mp mice (data not shown).

Serological analyses were performed in order to establish whether the Tg autoAbs were expressed. The different cohorts of mice were bled at different time points, and the data presented here are those obtained at 10 month of age when the mice were sacrificed. Substantial levels of idiotype^+^ IgM, IgG3, IgG2a and IgG2b Abs were detected in the V~H~3H9R/V~L~κ8R.MRL/Mp and in V~H~3H9R.MRL/Mp mice indicating that the anti-DNA knock-in Tg alleles on this background were not regulated by anergy unlike when on the C57BL/6 background ([Fig. 1](#fig1){ref-type="fig"}). In the V~H~3H9R/V~L~κ8R.MRL/Mp.*C1qa*^−/−^ mice the levels of idiotype^+^ Abs were similar to those detected in the strain-matched C1q-sufficient animals. In contrast, the V~H~3H9R.MRL/Mp.*C1qa*^−/−^ mice had significantly increased levels of idiotype^+^ IgM and IgG3 Abs compared to the V~H~3H9R.MRL/Mp mice ([Fig. 1](#fig1){ref-type="fig"}A and B), but similar levels of idiotype^+^ IgG2a and IgG2b Abs ([Fig. 1](#fig1){ref-type="fig"}C and D).

We then measured the levels of IgM and IgG autoAbs. A significant increase in the titre of IgM anti-ssDNA Abs was observed in the V~H~3H9R/V~L~κ8R.MRL/Mp.*C1qa*^−/−^ mice compared to the V~H~3H9R/V~L~κ8R.MRL/Mp mice ([Fig. 2](#fig2){ref-type="fig"}A). Of note, the V~H~3H9R/V~L~κ8R.MRL/Mp.*C1qa*^−/−^ mice displayed only markedly increased levels of IgM autoAbs directed against ssDNA (the specificity encoded by the Tg alleles) but not against other lupus autoantigens such as dsDNA, histone or chromatin ([Fig. 2](#fig2){ref-type="fig"}B--D). In the V~H~3H9R.MRL/Mp mice the pairing of the V~H~3H9 with endogenous L chains could yield to more specificities. Consistent with this, V~H~3H9R.MRL/Mp.*C1q*^−/−^ mice had significantly increased levels of IgM anti-ssDNA, anti-dsDNA, anti-histone and anti-chromatin Abs ([Fig. 2](#fig2){ref-type="fig"}A--D). We then analysed the levels of IgG autoAbs and found that these were similar between the C1q-sufficient and -deficient cohorts ([Supporting information Table S1](#app1){ref-type="sec"}).

3.2. Renal assessment
---------------------

At 10 month of age all the animals were sacrificed. V~H~3H9R/V~L~κ8R.MRL/Mp and V~H~3H9R.MRL/Mp animals showed histological evidence of a mild glomerulonephritis (median score 1.0, range: 0.0--3.0 and 1.5, range: 1.0--3.0, respectively) reminiscent of the disease observed in MRL/Mp non-Tg mice ([@bib32]). C1q-deficiency in MRL/Mp mice has previously been shown to worsen the kidney pathology ([@bib32]). However, in the Tg mice the absence of C1q did not exacerbate the renal disease compared to the strain-matched C1q-sufficient mice (V~H~3H9R/V~L~κ8R.MRL/Mp.*C1qa*^−/−^ mice: median score 1.0, range: 0.0--3.0, *p* = 0.4287; V~H~3H9R.MRL/Mp.*C1qa*^−/−^ mice: median range 2.0, range: 1.0--2.0, *p* = 0.4564).

3.3. Flow cytometric analysis of splenic and peritoneal B cells
---------------------------------------------------------------

In order to determine if the serological data were accompanied by phenotypic changes in T and B lymphocytes, we performed a comprehensive analysis of the various splenic and peritoneal subpopulations. Cells of at least 7 mice from each cohort were analysed by FACS at the time of the sacrifice using the combinations of markers shown in [Table 1](#tbl1){ref-type="table"}. In agreement with the findings in other genetic backgrounds ([@bib24]), the V~H~3H9R.MRL/Mp mice had a larger marginal zone (MZ) B cell population compared to V~H~3H9R/V~L~κ8R.MRL/Mp ([Fig. 3](#fig3){ref-type="fig"}A) and an increased proportion of idiotype^+^ B cells in the MZ compartment compared to follicular (FO) compartment (5.9 ± 1.0 versus 4.2 ± 0.6, paired *t*-test *p* = 0.0157) ([Table 1](#tbl1){ref-type="table"}). More interestingly, in the V~H~3H9R.MRL/Mp.*C1qa*^−/−^ mice, which produced higher levels of IgM autoAbs, the MZ B cell population was significantly decreased compared to the V~H~3H9R.MRL/Mp animals ([Fig. 3](#fig3){ref-type="fig"}A) and less idiotype^+^ B cells were found in the MZ compared to the FO compartment (3.4 ± 0.7 versus 4.8 ± 1.1, paired *t*-test *p* = 0.0042) ([Table 1](#tbl1){ref-type="table"}). In the V~H~3H9R/V~L~κ8R.MRL/Mp mice there was no preferential localization of idiotype^+^ B cells in the MZ zone (paired *t*-test *p* = 0.056) ([Table 1](#tbl1){ref-type="table"}). C1q deficiency was associated with a significant reduction in the percentage of MZ B cells ([Fig. 3](#fig3){ref-type="fig"}A) and a decrease of idiotype^+^ B cells in the MZ compared to the FO area (4.2 ± 0.9 versus 17.5 ± 3.2, paired *t*-test *p* = 0.0013). These findings indicated that MZ B cells might have been activated in the absence of C1q. Activated MZ B cells have been shown to migrate into the T cell zone and differentiate into plasma cells. Indeed, the percentage of plasma cells was increased in the two C1q-deficient cohorts compared to the respective MRL/Mp controls ([Fig. 3](#fig3){ref-type="fig"}B).

The peritoneal cavity in mice has been shown to be a site where some self-reactive B cells can escape tolerance ([@bib17]) and B-1 cells, one of the major sources of circulating IgM, accumulate. More cells were recovered from the peritoneum of V~H~3H9R.MRL/Mp.*C1qa*-/-mice compared to V~H~3H9R.MRL.Mp mice (*p* = 0.0051) but not in the V~H~3H9R/V~L~κ8R.MRL/Mp.*C1qa*^−/−^ versus V~H~3H9R/V~L~κ8R.MRL/Mp animals (*p* = 0.1923) ([Table 1](#tbl1){ref-type="table"}). When the peritoneal B cell subpopulations were analyzed in more detail, all subsets were increased in the V~H~3H9R.MRL/Mp.*C1qa*-/mice compared to the V~H~3H9R.MRL.Mp mice ([Table 1](#tbl1){ref-type="table"}). On the contrary, in the V~H~3H9R/V~L~κ8R C1q-deficient animals only B-1a cells were slightly increased compared to their wild type strain-matched controls ([Table 1](#tbl1){ref-type="table"}), but this did not reach statistical significance (*p* = 0.0518). We then analysed the V~H~3H9/V~L~κ8 idiotype expression on the different peritoneal B cells. Surprisingly in the peritoneum of the V~H~3H9R/V~L~κ8R.MRL.Mp and V~H~3H9R.MRL.Mp mice the majority of the B cells were not expressing the V~H~3H9/V~L~κ8 idiotype ([Table 1](#tbl1){ref-type="table"}). Of note the C1q-deficient mice had similar percentage of idiotype^+^ B cells in the different peritoneal B cell subpopulations compared to C1q-sufficient mice. The reduced proportion of idiotype^+^ B cells in the peritoneum compared to the peripheral blood and the spleen (data not shown) suggests that in this organ the B cells either preferentially used the endogenous alleles or had been activated and undergone editing.

4. Discussion
=============

C1q deficiency in humans and in mice has been associated with the development of a lupus-like illness. However, the role of C1q in the regulation of autoreactive B cells remains debatable. Here, we explored the regulation of autoreactive B cells by C1q using anti-DNA knock-in Tg models (V~H~3H9R/V~L~κ8R and V~H~3H9R) on the lupus prone MRL/Mp genetic background. The analysis of these mice revealed that the MRL/Mp background was in itself sufficient to allow the expression of anti-DNA Tg autoAbs and that the lack of C1q modified this effect only in the single Tg model (V~H~3H9R). However, in the absence of C1q the MZ B cell compartment was significantly reduced in both models and this was accompanied by an increase in plasmocytes.

Recently the V~H~3H9R/V~L~κ8R anti-DNA knock-in Tg model has been widely used for investigating the mechanisms of regulation of autoAb production in murine models of SLE. There is an increasing evidence that the V~H~3H9R/V~L~κ8R and V~H~3H9R anti-DNA Tg B cells, which have a relatively weak affinity to ssDNA, are regulated by anergy on normal genetic backgrounds such as BALB/c and C57BL/6, but could be induced to lose tolerance when transferred onto lupus models such as (NZB × NZW)F1 or MRL/Mp.*lpr*/*lpr* ([@bib4; @bib9; @bib16; @bib20; @bib45]). In light of these observations it was important for our study to establish whether the autoimmune prone MRL/Mp background was in itself capable of breaking tolerance. MRL/Mp mice are known to develop a mild autoimmune disease which can be accelerated with different disease-modifying genes such as *Yaa* ([@bib30]), *lpr* and *gld* ([@bib12]). The analysis of the idiotype^+^ (V~H~3H9R/V~L~κ8R) Abs revealed that the Tg MRL/Mp mice indeed had in circulation these idiotype^+^ Abs (IgM, IgG2a, IgG2b, IgG3) indicating that a break of tolerance had spontaneously occurred in these mice. One explanation for this is an intrinsic defect in MRL/Mp B cells and there is some evidence in support of this. MRL/Mp mice have been reported to exhibit a defect in maintaining the developmental arrest of V~H~3H9/V~L~λ anti-dsDNA conventional Tg B cells ([@bib29; @bib28]) and to have a spontaneous B cell hyperactivity in the absence of Ag in the Ig^HEL^ experimental model ([@bib35]). However, the V~H~3H9/V~L~λ anti-dsDNA autoreactive B cells, despite not being any longer developmentally arrested as in a BALB/c mice, exhibited follicular exclusion and failed to differentiate into plasma cells ([@bib29]). Furthermore Tg MRL/Mp mice expressing Ig^HEL^ have been shown to be able to down-regulate their B cell receptor and to be unable to secrete detectable levels of anti-HEL Abs in the presence of sufficient amount of sHEL ([@bib35]). Similarly anti-laminin Tg MRL/Mp mice were found to be tolerant ([@bib43]). Another potential explanation for the break of the B cell tolerance in the V~H~3H9R/V~L~κ8R anti-DNA Tg mice, is that in this model the MRL/Mp background was able to provide sufficient T cell help and the presence of idiotype^+^ IgG subclasses favour this hypothesis.

We next examined whether C1q could modulate the phenotype of the anti-ssDNA Tg B cells. In the V~H~3H9R/V~L~κ8R.MRL/Mp mice the absence of C1q increased significantly the circulating levels of IgM against ssDNA but not against other autoantigens including dsDNA. As the pairing of V~H~3H9 with V~L~κ8 prevents the binding of V~H~3H9 to dsDNA, the elevated amount of IgM anti-ssDNA observed could have been the result of an increased Tg expression. However, the idiotype analysis failed to demonstrate a difference in the levels of IgM idiotype^+^ Abs between V~H~3H9R/V~L~κ8R.MRL/Mp.*C1qa*^−/−^ and V~H~3H9R/V~L~κ8R.MRL/Mp mice, questioning whether the source of the increased levels of IgM anti-ssDNA was indeed the Tg B cells. On the other hand, the V~H~3H9R.MRL/Mp.*C1qa*^−/−^ mice displayed significantly higher levels of IgM and IgG3 idiotype^+^ Abs. As the V~H~3H9R heavy chain can pair with different endogenous light chains generating a wider range of autoAbs, other specificities were tested. Indeed the absence of C1q increased significantly IgM levels against all the lupus autoantigens analysed.

To gain insight into the mechanisms regulating the autoAb production in the C1q-deficient mice we then carried a detailed analysis of the different B cell populations. Several studies have proposed a possible role for MZ B cells in the development of lupus in mouse models. Although studies in immunoglobulin Tg mice have shown that autoreactive B cells can accumulate in the marginal zone under various experimental situations ([@bib24; @bib26; @bib29; @bib27; @bib40; @bib48]), it remains to be established whether MZ B cells secrete pathogenic autoAbs in any model of lupus. B cells producing potentially pathogenic autoAbs are thought to home to the MZ ([@bib11; @bib24]) and sequestration to this site is believed to prevent them from entering into the germinal centres and developing the properties of pathogenic B cells. However, recent studies in lupus-prone mice have reported both enlargements ([@bib22; @bib25; @bib49]) and impaired development of the MZ B cell compartment ([@bib1; @bib44]). Consistent with previous observations in the V~H~3H9R/V~L~κ8R model ([@bib48]), the MZ was found to be enlarged in the V~H~3H9R.MRL/Mp mice but no accumulation of MZ B cells was observed in V~H~3H9R/V~L~κ8R.MRL/Mp mice. Importantly C1q deficiency decreased dramatically the proportion of MZ B cells in these mice and this was accompanied by an increase in the percentage of plasma cells. More interestingly, in the C1q-deficient Tg mice we observed a significant disappearance of idiotype^+^ B cells from the MZ suggesting that these cells had been activated. Marginal zone B cells bearing low affinity self-reactive BCR can react to repetitive Ag and produce natural autoAbs of the IgM isotype upon contact with blood-borne pathogens or self Ag ([@bib36]). Moreover, MZ B cells can undergo T cell independent switching to IgG, IgA and IgE in response to pathogen associated molecular patterns (PAMP). As C1q has been shown to be involved in the clearance of apoptotic cells, which are enriched in the typical lupus autoantigens, one could postulate that the increased IgM Tg secretion and the reduction of the MZ B cells in the V~H~3H9R.MRL/Mp.*C1qa*^−/−^ mice might be related to a failure to clear antigens associated with dying cells. In the absence of C1q the ineffectively cleared autoAgs could stimulate the autoreactive MZ Tg B cells to differentiate into plasmocyte resulting into the decrease of MZ B cells and increase of circulating IgM autoAbs. Similarly, in the spleens of V~H~3H9R/V~L~κ8R.MRL/Mp.*C1qa*^−/−^ mice significantly less idiotype^+^ B cells were present in the MZ compartment and more plasmocytes were found. However, these cellular changes were not paralleled by an increase of idiotype^+^ IgM Abs in circulation indicating in this model they were not sufficient to induce autoantibody production.

Another potential source of IgM autoAbs are the B1 cells. B1 cells have long been associated with the secretion of natural Abs against self and foreign pathogens, which can occur without obvious inflammatory response. The importance of B1 cells in the pathogenesis of lupus continues to be debated. A major argument for a role of B1a cells in mouse lupus relates to the expansion of this subset in NZB and (NZB × NZW)F1 mice. Reduction of B1 cells for instance via intraperitoneal injection of H~2~O delayed disease onset and reduced disease severity in (NZB × NZW)F1 mice ([@bib33]). However, the expansion of B1a cells was shown not to be critical for the production of IgM or IgG autoAbs in this murine model of SLE ([@bib2]). The Abs secreted by B1 cells tend to be polyreactive with low-affinity cross-reactivity to a variety of self Ags and these characteristics are very different from the pathogenic IgG Abs produced by lupus mice. In our experimental model, we found an increase in the total number of peritoneal and B1 cells in the V~H~3H9R.MRL/Mp.*C1qa*^−/−^ mice compared to their wild type counterparts ([Table 1](#tbl1){ref-type="table"}). A similar trend was observed for the B1a cells in the V~H~3H9R/V~L~κ8R.MRL/Mp.*C1qa*^−/−^ mice but this did not reach statistical significance. However, in both models the percentages of idiotype^+^ B1 cells between C1q-deficient and -sufficient mice were similar. These findings would indicate the lack of C1q may favour the expansion of peritoneal B1 cells and that these cells might have contributed to the increase of serum IgM autoAb levels observed in the V~H~3H9R.MRL/Mp C1q-deficient mice. Supporting this hypothesis, a recent study showed that C1q deficiency increases the positive selection of B-1 cells and IgM autoAb production by a membrane-bound intracellular auto-Ag ([@bib19]).

In conclusion, using mice expressing site-directed transgenes for anti-DNA autoAbs we have shown that: (i) the MRL/Mp background was in itself capable of inducing the expression of anti-DNA Tg autoAbs, and (ii) V~H~3H9R.MRL/Mp.*C1qa*^−/−^ could influence the production of Tg-derived IgM and IgG3 autoAbs possibly as a result of an impaired disposal of cellular debris. However, we found no evidence of a direct role of C1q in the regulation of self-reactive conventional B cells. Further studies on non-lupus prone genetic backgrounds such as C57BL/6 will be necessary to determine if C1q deficiency can play a more substantial role in shaping the repertoire of the autoreactive B cells.
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![Expression of idiotype^+^ (A) IgM, (B) IgG3, (C) IgG2a and (D) IgG2b immunoglobulins in circulation. The combination of V~H~3H9R/V~L~κ8R was assessed using a specific anti-idiotype mAb (1.209). Ten month-old V~H~3H9R/V~L~κ8R.MRL/Mp (closed diamonds) and V~H~3H9R.MRL/Mp (closed triangles) mice displayed detectable levels of idiotype^+^ IgM, IgG3, IgG2a and IgG2b Abs. IgM and IgG3 levels were markedly increased in V~H~3H9R.MRL/Mp.*C1qa*^−/−^ mice. C1q-deficient mice are represented with open symbols. Each symbol represents one mouse, horizontal bars indicate median.](gr1){#fig1}

![AutoAb profiles. Serology at 10 months of age in V~H~3H9R/V~L~κ8R.MRL/Mp (diamonds) and V~H~3H9R.MRL/Mp (triangles) mice. C1q-deficient mice are represented with open symbols. Each symbol represents one mouse, horizontal bars indicate median. (A) IgM anti-ssDNA Abs; (B) IgM anti-dsDNA Abs; (C) IgM anti-histone Abs; (D) IgM anti-chromatin Abs measured by ELISA as described in Section [2](#sec1){ref-type="sec"}.](gr2){#fig2}

![Flow cytometric analysis of splenic and peritoneal cells. In C1q-deficient mice there was a reduction of (A) marginal zone B cells (percentage of CD21^high^CD23^low^, CD19^+^ gated splenic B cells) and this was associated with an increase of (B) plasma cells (percentage of CD138^+^, B220^−^CD90^−^ gated splenic cells). Each symbol represents one mouse; V~H~3H9R/V~L~κ8R.MRL/Mp mice (diamonds) and V~H~3H9R.MRL/Mp mice (triangles); C1q-deficient mice are represented with open symbols.](gr3){#fig3}

###### 

Splenic and peritoneum cell populations at 10 months of age

  Cell populations                     Staining                          V~H~3H9R/V~L~κ8R MRL/Mp   V~H~3H9R/V~L~κ8R MRL/Mp.*C1qa*^−/−^            V~H~3H9R MRL/Mp   V~H~3H9R MRL/Mp.*C1qa*^−/−^
  ------------------------------------ --------------------------------- ------------------------- ---------------------------------------------- ----------------- -----------------------------------------------
  *n* Splenic cells (10^7^)                                              11.0 ± 1.3                14.9 ± 1.9                                     12.2 ± 1.7        14.1 ± 1.8
                                                                                                                                                                    
  *n* B cells (10^6^)                  B220^+^CD5^−^                     32.3 ± 3.8                29.5 ± 3.4                                     47.5 ± 7.0        36.4 ± 5.6
  *n* T cells (10^6^)                  CD5^+^B220^−^                     52.7 ± 7.1                68.3 ± 13.0                                    74.1 ± 11.9       80.5 ± 10.7
  *n* B-1 cells (10^6^)                B220^+^CD5^+^                     4.3 ± 0.7                 4.5 ± 0.7                                      3.6 ± 0.5         3.1 ± 0.4
                                                                                                                                                                    
  *n* T1 B cells (10^6^)               CD21/35^lo^CD23^lo^, CD19 gated   4.8 ± 0.9                 3.4 ± 0.4                                      10.5 ± 3.3        5.2 ± 0.8
  *n* MZ B cells (10^6^)               CD21/35^hi^CD23^lo^, CD19 gated   8.7 ± 1.8                 4.1 ± 0.7[\#](#tbl1fn2){ref-type="table-fn"}   14.8 ± 2.2        9.5 ± 1.5[\*](#tbl1fn1){ref-type="table-fn"}
  *n* FO B cells (10^6^)               CD21/35^+^CD23^hi^, CD19 gated    13.5 ± 1.4                17.3 ± 2.2                                     14.3 ± 2.9        17.4 ± 3.2
  *n* Plasmocytes (10^6^)              CD138^+^, CD90.2^−^ CD19 gated    0.7 ± 0.1                 1.1 ± 0.1[\#](#tbl1fn2){ref-type="table-fn"}   1.3 ± 0.2         1.5 ± 0.2
                                                                                                                                                                    
  *n* Idiotype^+^ MZ B cells (10^6^)   1.209^+^, MZ gated                8.8 ± 2.0                 4.2 ± 0.9[\#](#tbl1fn2){ref-type="table-fn"}   5.9 ± 1.0         3.4 ± 0.7[\*](#tbl1fn1){ref-type="table-fn"}
  *n* Idiotype^+^ FO B cells(10^6^)    1.209^+^, FO gated                12.8 ± 1.6                17.5 ± 3.2                                     4.2 ± 0.6         4.8 ± 1.1
                                                                                                                                                                    
  *n* Peritoneal cells (10^6^)                                           3.1 ± 0.5                 4.1 ± 0.5                                      3.5 ± 0.5         5.8 ± .06[\*](#tbl1fn1){ref-type="table-fn"}
  *n* B-1a B cells (10^5^)             CD5^+^CD11b^lo^, CD19^+^ gated    1.8 ± 0.3                 3.8 ± 1.0                                      3.1 ± 1.0         7.8 ± 1.9[\*](#tbl1fn1){ref-type="table-fn"}
  *n* B-1b B cells (10^5^)             CD5^−^CD11b^+^, CD19^+^ gated     10.0 ± 1.6                10.6 ± 1.6                                     11.8 ± 1.8        18.2 ± 1.4[\*](#tbl1fn1){ref-type="table-fn"}
  *n* B-2 B cells (10^5^)              CD5^−^CD11b^−^, CD19^+^ gated     8.8 ± 1.5                 10.0 ± 1.7                                     7.9 ± 1.6         13.9 ± 2.0[\*](#tbl1fn1){ref-type="table-fn"}
                                                                                                                                                                    
  \% Idiotype^+^ B-1a B cells          1.209^+^, B-1a gated              38.8 ± 4.4                26.4 ± 6.9                                     16.2 ± 2.9        12.7 ± 2.2
  \% Idiotype^+^ B-1b B cells          1.209^+^, B-1b gated              32.1 ± 3.4                23.8 ± 4.0                                     20.4 ± 2.3        19.3 ± 3.4
  \% Idiotype^+^ B-2 B cells           1.209^+^, B-2 gated               53.5 ± 5.4                45.3 ± 7.0                                     15.6 ± 1.7        12.8 ± 1.6

Results are shown as mean ± S.E.M.; MZ: marginal zone; FO: follicular zone.

*p*-Value \< 0.05 V~H~3H9R.MRL/Mp vs. V~H~3H9R.MRL/Mp.*C1qa*^−/−^.

*p*-Value \< 0.05 V~H~3H9R/V~L~κ8R.MRL/Mp vs. V~H~3H9R/V~L~κ8R.MRL/Mp.*C1qa*^−/−^, *n* = number.

[^1]: Present address: The Wellcome Trust, 183 Euston Road, London NW1 2BE, UK.
